ArticleBioMed research international2013

HOXA4 gene promoter hypermethylation as an epigenetic mechanism mediating resistance to imatinib mesylate in chronic myeloid leukemia patients.

Marjanu Hikmah Elias et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.